Association analysis between MDR1 gene polymorphisms and risk of hepatocellular carcinoma in Chinese population

Biomarkers

Volumn 18, Issue 3, 2013, Pages 236-241

  Yang, Daokun ^a   Zhou, Fujun ^a   Wang, Xinwei ^a   Gao, Haili ^a   Li, Guangyan ^a   Xue, Minghui ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Molecular marker; Multidrug resistance 1 gene; Risk factors; Single nucleotide polymorphisms; Susceptibility

Indexed keywords

GENOMIC DNA; MOLECULAR MARKER; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ALLELE; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MDR1 GENE; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, GENETIC; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84876530315     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.773079     Document Type: Article

References (42)

1. Amarapurkar DN, Patel ND, Kamani PM. (2008). Impact of diabetes mellitus on outcome of HCC. Ann Hepatol 7: 148-51. (Pubitemid 351845526)
2. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. (2003). P-glycoprotein: from genomics to mechanism. Oncogene 22: 7468-85. (Pubitemid 37487170)
3. Bosch FX, Ribes J, Diaz M, Cleries R. (2004). Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-16. (Pubitemid 39423365)
4. Cavaco I, Gil JP, Gil-Berglund E, Ribeiro V. (2003). CYP3A4 and MDR1 alleles in a Portuguese population. Clin Chem Lab Med 41: 1345-50. (Pubitemid 37266126)
5. Chen JG, Zhang SW, Chen WQ. (2010). Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2004-2005. Zhonghua Yu Fang Yi Xue Za Zhi 44: 383-9.
6. Chen XJ, Wang XG, Shen YJ, et al. (2011). Correlation of MDR1 single nucleotide polymorphism with prognosis of hepatocellular carcinoma. J Chin Oncol 17: 209-11.
7. Chen YD, Yang F, Feng ST, Zhang YX. (2009). A case-control study on the association between genetic polymorphisms of MDR1 and hepatic cell cancer susceptibility. Chin Clin Oncol 14: 1077-81.
8. Chinn LW, Kroetz DL. (2007). ABCB1 pharmacogenetics: progress, pitfalls, and promise. Clin Pharmacol Ther 81: 265-9. (Pubitemid 46174824)
9. El-Serag HB, Rudolph KL. (2007). Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-76. (Pubitemid 46890874)
10. Farazi PA, DePinho RA. (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6: 674-87. (Pubitemid 44286000)
11. Fromm MF. (2002). Genetically determined differences in P-glycoprotein function: implications for disease risk. Toxicology 181-182: 299-303. (Pubitemid 36015717)
12. Gomaa AI, Khan SA, Toledano MB, et al. (2008). Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14: 4300-8.
13. Goto M, Masuda S, Kiuchi T, et al. (2008). Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation. J Pharmacol Exp Ther 325: 610-16. (Pubitemid 351574803)
14. Haliassos A, Chomel JC, Tesson L, et al. (1989). Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17: 3606. (Pubitemid 19120470)
15. Hoffmeyer S, Burk O, von Richter O, et al. (2000). Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97: 3473-8. (Pubitemid 30183327)
16. Jamroziak K, Mlynarski W, Balcerczak E, et al. (2004). Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 72: 314-21. (Pubitemid 38520728)
17. Kaya P, Gunduz U, Arpaci F, et al. (2005). Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients. Am J Hematol 80: 26-34. (Pubitemid 41254264)
18. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. (2007). A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-8. (Pubitemid 46175758)
19. Kurzawski M, Drozdzik M, Suchy J, et al. (2005). Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol 61: 389-94. (Pubitemid 41569314)
20. Leonessa F, Clarke R. (2003). ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 10: 43-73. (Pubitemid 36457239)
21. Llovet JM, Burroughs A, Bruix J. (2003). Hepatocellular carcinoma. Lancet 362: 1907-17. (Pubitemid 37518510)
22. Marrero JA, Fontana RJ, Fu S, et al. (2005). Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42: 218-24. (Pubitemid 40143468)
23. Masuda S, Goto M, Fukatsu S, et al. (2006). Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in livingdonor liver transplant patients. Clin Pharmacol Ther 79: 90-102. (Pubitemid 43069581)
24. Nault JC, Zucman-Rossi J. (2011). Genetics of hepatobiliary carcinogenesis. Semin Liver Dis 31: 173-87.
25. Parikh S, Hyman D. (2007). Hepatocellular cancer: a guide for the internist. Am J Med 120: 194-202. (Pubitemid 46341174)
26. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
27. Pechandova K, Buzkova H, Slanar O, Perlik F. (2006). Polymorphisms of the MDR1 gene in the Czech population. Folia Biol (Praha) 52: 184-9. (Pubitemid 46020161)
28. Schutte K, Bornschein J, Malfertheiner P. (2009). Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis 27: 80-92.
29. Sohn JW, Lee SY, Lee SJ, et al. (2006). MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol 36: 137-41.
30. Suriawinata A, Xu R. (2004). An update on the molecular genetics of hepatocellular carcinoma. Semin Liver Dis 24: 77-88. (Pubitemid 38496050)
31. Taniguchi S, Mochida Y, Uchiumi T, et al. (2003). Genetic polymorphism at the 50 regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon. Mol Cancer Ther 2: 1351-9.
32. Thorgeirsson SS, Grisham JW. (2002). Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-46. (Pubitemid 35154440)
33. Vander Borght S, Komuta M, Libbrecht L, et al. (2008). Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin. Liver Int 28: 1370-80.
34. Wang D, Johnson AD, Papp AC, et al. (2005). Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C4T affects mRNA stability. Pharmacogenet Genomics 15: 693-704. (Pubitemid 41345321)
35. Wu L, Xu X, Shen J, et al. (2007). MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation. J Surg Oncol 96: 62-8. (Pubitemid 47015450)
36. Yu X, Xie H, Wei B, et al. (2011). Association of MDR1 gene SNPs and haplotypes with the tacrolimus dose requirements in Han Chinese liver transplant recipients. PLoS One 6: e25933.
37. Yuan ZR, Li J, Li JY, et al. (2013a). SNPs identification and its correlation analysis with milk somatic cell score in bovine MBL1 gene. Mol Biol Rep 40: 7-12.
38. Yuan ZR, Li JY, Li J, et al. (2013b). Effects of DGAT1 gene on meat and carcass fatness quality in Chinese commercial cattle. Mol Biol Rep 40: 1947-54.
39. Yuan ZR, Li J, Zhang LP, et al. (2012). Investigation on BRCA1 SNPs and its effects on mastitis in Chinese commercial cattle. Gene 505: 190-4.
40. Zeng X, Liu S, Yu H, et al. (2012). DNA repair capacity, DNA-Strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in Southwestern Guangxi of China. DNA Cell Biol 31: 1384-91.
41. Zhao CJ, Li N, Deng XM. (2003). The establishment of method for identifying SNP genotype by CRS-PCR. Yi Chuan 25: 327-9.
42. Zhou SF. (2008). Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38: 802-32.